[Research progress of traditional Chinese medicine in regulating "inflammation-cancer" transformation in gastric mucosa based on NLRP3 inflammasome].

Q3 Pharmacology, Toxicology and Pharmaceutics
Liu-Hong Yang, Jia Liu, Lan Liang, Jie Lin
{"title":"[Research progress of traditional Chinese medicine in regulating \"inflammation-cancer\" transformation in gastric mucosa based on NLRP3 inflammasome].","authors":"Liu-Hong Yang, Jia Liu, Lan Liang, Jie Lin","doi":"10.19540/j.cnki.cjcmm.20250104.401","DOIUrl":null,"url":null,"abstract":"<p><p>Gastric cancer is one of the most common malignant tumors in the digestive tract, which has the characteristics of high morbidity and mortality. However, gastric cancer is not achieved overnight but is gradually developing through the interaction of many factors. Therefore, actively delaying or blocking the &quot;inflammation-cancer&quot; transformation in gastric mucosa is the key to treatment. Nod-like receptor protein 3(NLRP3) inflammasome is a multi-protein signal complex and one of the important innate immune signal receptors. Inflammation plays an important role in the occurrence and development of gastric cancer, and continuous inflammation mediation will trigger the transformation from inflammation to cancer. Therefore, the significance of NLRP3 inflammasome to gastric mucosa lies in the transformation between inflammation and cancer. Traditional Chinese medicine(TCM) has the functions of multi-components, multi-targets, and few adverse reactions. A large number of studies show that TCM and related monomers have significant effects in treating liver, kidney, and immune diseases through mediating NLRP3 inflammasome, but there is less research on the &quot;inflammation-cancer&quot; transformation in gastric mucosa. By combing the NLRP3-related nuclear factor-κB transcription factor(NF-κB), hypoxia inducible factor-1α(HIF-1α), phosphatidylinositol 3-kinase/protein kinase B(PI3K/Akt), and other signal pathways, this paper clarified their mechanisms in the &quot;inflammation-cancer&quot; transformation in gastric mucosa, delayed the process of &quot;inflammation-cancer&quot; transformation in gastric mucosa through four aspects: energy metabolism, pyroptosis, immune response, and vascular endothelial growth factor, and prevented and treated &quot;inflammation-cancer&quot; transformation in gastric mucosa from three aspects: TCM monomer, TCM compound prescription, and other therapies, so as to provide ideas for the subsequent treatment of &quot;inflammation-cancer&quot; transformation in gastric mucosa with TCM.</p>","PeriodicalId":52437,"journal":{"name":"Zhongguo Zhongyao Zazhi","volume":"50 9","pages":"2334-2348"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhongguo Zhongyao Zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19540/j.cnki.cjcmm.20250104.401","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Gastric cancer is one of the most common malignant tumors in the digestive tract, which has the characteristics of high morbidity and mortality. However, gastric cancer is not achieved overnight but is gradually developing through the interaction of many factors. Therefore, actively delaying or blocking the "inflammation-cancer" transformation in gastric mucosa is the key to treatment. Nod-like receptor protein 3(NLRP3) inflammasome is a multi-protein signal complex and one of the important innate immune signal receptors. Inflammation plays an important role in the occurrence and development of gastric cancer, and continuous inflammation mediation will trigger the transformation from inflammation to cancer. Therefore, the significance of NLRP3 inflammasome to gastric mucosa lies in the transformation between inflammation and cancer. Traditional Chinese medicine(TCM) has the functions of multi-components, multi-targets, and few adverse reactions. A large number of studies show that TCM and related monomers have significant effects in treating liver, kidney, and immune diseases through mediating NLRP3 inflammasome, but there is less research on the "inflammation-cancer" transformation in gastric mucosa. By combing the NLRP3-related nuclear factor-κB transcription factor(NF-κB), hypoxia inducible factor-1α(HIF-1α), phosphatidylinositol 3-kinase/protein kinase B(PI3K/Akt), and other signal pathways, this paper clarified their mechanisms in the "inflammation-cancer" transformation in gastric mucosa, delayed the process of "inflammation-cancer" transformation in gastric mucosa through four aspects: energy metabolism, pyroptosis, immune response, and vascular endothelial growth factor, and prevented and treated "inflammation-cancer" transformation in gastric mucosa from three aspects: TCM monomer, TCM compound prescription, and other therapies, so as to provide ideas for the subsequent treatment of "inflammation-cancer" transformation in gastric mucosa with TCM.

[基于NLRP3炎性体的中药调节胃黏膜“炎-癌”转化的研究进展]。
胃癌是消化道最常见的恶性肿瘤之一,具有高发病率和死亡率的特点。然而,胃癌的发生不是一蹴而就的,而是在多种因素的相互作用下逐渐发展起来的。因此,积极延缓或阻断“炎症-癌变”;胃粘膜转化是治疗的关键。nod样受体蛋白3(NLRP3)炎性小体是一种多蛋白信号复合物,是重要的先天免疫信号受体之一。炎症在胃癌的发生发展中起着重要作用,持续的炎症介导会引发由炎症向癌症的转化。因此,NLRP3炎性体对胃粘膜的意义在于炎症与癌之间的转化。中药具有多成分、多靶点、不良反应少的特点。大量研究表明,中药及相关单体通过介导NLRP3炎性体对肝、肾、免疫等疾病均有显著疗效,但对“炎症-肿瘤”的研究较少。胃粘膜的转化。通过结合nlrp3相关核因子-κB转录因子(NF-κB)、缺氧诱导因子-1α(HIF-1α)、磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/Akt)等信号通路,阐明其在“炎症-肿瘤”中的作用机制。胃黏膜转化,延缓“炎性-癌变”进程;胃粘膜通过能量代谢、焦亡、免疫反应、血管内皮生长因子四方面转化,预防和治疗“炎性-癌变”;从中药单体、中药复方及其他疗法三个方面探讨胃粘膜的变化,为“炎-癌”的后续治疗提供思路;中药对胃粘膜的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Zhongguo Zhongyao Zazhi
Zhongguo Zhongyao Zazhi Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.50
自引率
0.00%
发文量
581
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信